NEWS 2011-11-28 7th Pharmaceutical Industry Conference On 22nd - 24th November 2011 in Rawa Mazowiecka the 7th Pharmaceutical Industry Conference was organized by BMP sp. z o.o. under the patronage of the Pharmaceutical Research Institute. 2011-09-05 GMP certificate for nitrendipine On 7th – 9th June 2011 the Pharmaceutical Research Institute was inspected by the Main Pharmaceutical Inspector (GIF) - the Competent Authority of Poland. The subject of the inspection was carvedilol, olanzapine, (+)-clopidogrel bisulfate and nitrendipine manufacturing in the Pilot Plant Department. 2011-08-25 G. Grynkiewicz joins Editorial Advisory Board of Chemistry & Biology Interface Professor Grzegorz Grynkiewicz became a member of the Editorial Advisory Board of a new international scientific journal Chemistry & Biology Interface. The journal covers multidiscipline topics in the area of chemistry, biology, biotechnology, medicine and pharmacy. 2011-08-04 Andrzej Kutner nominated to Professor The President of the Republic of Poland nominated Andrzej Kutner to the title of Professor in the area of pharmaceutical sciences. 2011-06-17 3rd World of the Pharmaceutical Industry Congress On 16th-17th June 2011 in Poznan the 3rd World of the Pharmaceutical Industry Congress was organized by Farmacom under the patronage of the Pharmaceutical Research Institute. 2011-04-01 PRIOMEDCHILD > PAMPER Pharmaceutical Research Institute (PRI) has joined European Program ERA-NET Priority Medicines for Children (PRIOMEDCHILD). The 36 month project entitled Paediatric Accelerator Mass Spectrometry Evaluation Research Study (PAMPER), commenced on April 1st 2011. 2010-10-23 PRI's new domain ifarm.eu The Pharmaceutical Research Institute's (PRI) domain was changed from ifarm.waw.pl to ifarm.eu. 2010-06-23 Imatinib - Polish Product of the Future On 23 May 2010 Pharmaceutical Research Institute (PRI) won the first award at the Polish Product of the Future 2008 Competition. PRI was awarded in the category Future Technology in Commercialization Phase for the project: Manufacturing technology of active substance Imatinib. 2010-04-06 PRI's cardio-vascular project supported by the EU (POIG 1.3.1) The Ministry of Science and Higher Education of the Republic of Poland has issued a positive opinion on the consecutive Pharmaceutical Research Institute (PRI) grant application for the Innovative Economy Operational Programme 2007-2013 (POIG), submeasure 1.3.1. The research project entitled Innovative technologies of Cardio-vascular medicines of special therapeutic and social importance gained the funding from the European Regional Development Fund (ERDF). 2010-02-10 GLP Certificate for the Pharmacology Department On 25-26 November 2009 and 26 January 2010 the Pharmacology Department of the Pharmaceutical Research Institute was audited by the Inspectors from the Bureau for Chemical Substances and Preparations. The knowledge gained during the inspection led to the conclusion that pharmacokinetic studies are performed according to the OECD principles of GLP. The quality of studies was confirmed by the Certificate of GLP Compliance. 2010-02-06 PRI's and WUM's project supported by the EU (POIG 1.1.2) The consortium project of Pharmaceutical Research Institute (PRI) and Medical University of Warsaw (WUM) entitled Research on innovative endothelium medicine among novel escin analogues gained financial support under Innovative Economy Operational Programme 2007-2013, submeasure 1.1.2. 2009-05-28 EUMAPP - Summary Report The European Microdosing AMS Partnership Programme (EUMAPP), funded by the European Union, was a major international, multi-centre research study involving collaboration between industry and academia. This summary report is concerned with the outcomes of the human microdose studies. 2009-02-12 PRI’s projects supported by the EU (POIG 1.3.1) The Ministry of Science and Higher Education of the Republic of Poland has issued a positive opinion on two Pharmaceutical Research Institute (PRI) grant applications for the Innovative Economy Operational Programme 2007-2013 (POIG), submeasure 1.3.1. Both research projects were recommended to be supported by the European Regional Development Fund (ERDF). 2009-02-01 Head of Pharmacology Department changes On 1 February 2009 Piotr Rudzki, M.Sc. became the head of the Pharmacology Department. The Pharmacology Department performs pharmacokinetic, bioavailability and bioequivalence studies according to the European Union regulations. 2008-11-28 GMP for Formulation Manufacturing Department On 26-28 November 2008 the Pharmaceutical Research Institute was inspected by the Main Pharmaceutical Inspector (GIF - the Competent Authority of Poland). The subject of the inspection was manufacturing of sterile products (lyophilisates) and non-sterile products (capsules, soft shell) in the Formulation Manufacturing Department. The quality of the manufacturing process was confirmed by the Certificate of GMP Compliance. 2008-11-20 New Certificate of GMP Compliance On 16-18 September 2008 the Pharmaceutical Research Institute was inspected by the Main Pharmaceutical Inspector (GIF – the Competent Authority of Poland). The subject of the inspection was manufacturing active pharmaceutical ingredients: carvedilol, clopidogrel and olanzapine. 2008-09-24 The inaugural session of the PRI’s Scientific Board On 24 September 2008 the PRI’s Scientific Board inaugural session was held in the Pharmaceutical Research Institute (PRI) in Warsaw marking its Sixth Term of Office. Prof. Lukasz Kaczmarek was elected as chairman and Prof. Andrzej Les was elected as deputy chairman. 2007-10-25 Janusz Obukowicz becomes the Director of PRI On 25 October 2007 the Minister of Economy Piotr Grzegorz Wozniak appointed Janusz Obukowicz, M.Sc., as Director of Pharmaceutical Research Institute, Warsaw, Poland. 2007-06-06 Pharmaceutical Research Institute celebrates its 55th Anniversary On 6 June 2007 Pharmaceutical Research Institute celebrated its 55th Anniversary. The anniversary lecture was delivered by Wieslaw Szelejewski, PhD. Some general information on PRI history and achievements was addressed. Subsequently, future plans were presented concerning mainly the recently modernised Pilot Plant. 2007-05-15 Pharmacology Department audited by SNAS On 15 May 2007 the Laboratory of Drugs Bioavailability (Pharmacology Department) was audited by SNAS. The outcome of the control was positive, the current GLP certificate remains valid through 11 January 2010. 2007-05-14 PRI Director changes The General Director of Pharmaceutical Research Institute, Wieslaw Szelejewski, Ph.D., has resigned. The Minister of Economy appointed Janusz Obukowicz, M.Sc., the Manager of Pharmaceutical Research Institute to perform General Director's duties until a contest will determine the company's new director. 2007-03-21 Professor G.Grynkiewicz honoured with the Availing People of Science Medal On 21 March 2007 professor Grzegorz Grynkiewicz was honoured with the Availing People of Science Medal by the Foundation for the Development of Polish Pharmacy and Medicine for his contribution to the development of the Foundation. 2007-03-19 Structural Research Laboratory On 26 January 2007 the Structural Research Laboratory (SRL) was officially launched. The Laboratory is dedicated to scientific, educational and commercial activities and is the first module of the Centre for the Advanced Technologies. SRL is located in the Radiochemistry Building of Warsaw University, at the Chemistry Department (101, Zwirki i Wigury Str.). 2007-02-15 Pharmaceutical Research Institute and Polish Pharmaceutical Holding (PHF S.A.) sign a letter of intent to cooperate Pharmaceutical Research Institute (PRI) and three companies of the Polish Pharmaceutical Holding (PHF S.A.): Polfa Warszawa S.A., Polfa Pabianice S.A. and Polfa Tarchomin S.A. announced on 15 February 2007 that they had signed a letter of intent to cooperate. Accordingly, the companies will develop and market new technologies for the active pharmaceutical ingredient (API) manufacturing, as well as generic and original medicinal products (including biotech). 2006-10-18 Drug Substance Synthesis Installation officially opened On October 18th 2006 Drug Substance Synthesis Installation was officially launched. The installation is GMP compliant.